As GLP-1 drugs like Ozempic surge in popularity, Dr. Vimal Pahuja warns of rising misuse, access inequality, and serious health risks in India.
Go to Source
Author: News18
Go to Source
Author: News18
Hot this week
Free News - Where voices unite, stories flourish, and community thrives through open dialogue and meaningful connections.
Get important news delivered directly to your inbox and stay connected!
